The stock is priced like a stalled software vendor with cash but weak proof of repeatable demand. If C3 stabilizes revenue, proves partner-led distribution, and improves burn, investors can
re-rate it toward a modest growth-software multiple; the upside comes from recovery plus better value capture in trusted, regulated workflows, not from a return to hype-era valuations.